Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

EU flag

Boehringer’s Giotrif wins new NSCLC licence in Europe

Can now be marketed for advanced squamous cell carcinoma of the lung

- PMLiVE

TxCell appoints global scientific advisory board

Prof Zelig Eshar, Prof Chiara Bonini and Dr Bernard Malissen join

- PMLiVE

Red Door Unlimited promotes Andrew Thomas

He takes up the role of deputy managing director

- PMLiVE

US tax changes claim Pfizer scalp as Allergan deal abandoned

Firm walks away from record-breaking $160bn merger after planned inversion rule changes released

- PMLiVE

FDA approves first Remicade biosimilar

Pfizer-Celltrion's Inflectra becomes the second biosimilar to be licensed in the US

- PMLiVE

Download ‘Perspective magazine issue 2: Human-centred design and strategy’

In the second issue of Perspective, the digital magazine from Blue Latitude Health, we tackle topics dealing with customer experience and customer and patient centricity.

Blue Latitude Health

- PMLiVE

Gilead boosts liver disease pipeline with $1.2bn acquisition

Also has combination HIV therapy Descovy approved by FDA

- PMLiVE

Juniper Pharmaceuticals adds to board of directors

Mary Ann Gray joins as audit committee chair

- PMLiVE

Dr Antoine Yver moves from AstraZeneca to Daiichi Sankyo

He becomes global head, oncology research and development

- PMLiVE

Delivering digital value

Improving outcomes, the digital responsibility

- PMLiVE

Teva and Takeda appoint head of Japanese generics venture

Hiroshi Matsumori will lead partnership of Teva’s generics portfolio and Takeda brands

- PMLiVE

Pfizer’s PCSK9 inhibitor clears another phase III trial

Bococizumab will compete with Praluent and Repatha if it reaches the market

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links